Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EchoIQ Limited ( (AU:EIQ) ) has shared an announcement.
Echo IQ Limited has issued 2,225,000 fully paid ordinary shares following the exercise of performance rights, expanding its quoted share capital on the ASX. The company confirmed the issuance was conducted without a prospectus under the Corporations Act’s disclosure exemptions and stated it remains compliant with its financial reporting and continuous disclosure obligations, with no excluded information, reinforcing regulatory transparency for existing and prospective shareholders.
The most recent analyst rating on (AU:EIQ) stock is a Buy with a A$0.62 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ Limited is an Australian AI-driven medical technology company based in Sydney that develops proprietary software to improve decision-making in cardiology, targeting clinicians and healthcare providers seeking advanced diagnostic support tools.
Average Trading Volume: 1,867,657
Technical Sentiment Signal: Buy
Current Market Cap: A$358.4M
See more data about EIQ stock on TipRanks’ Stock Analysis page.